{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-25-010916","form_type":"8-K","ticker":"FHTX","cik":"0001822462","company_name":"Foghorn Therapeutics Inc.","filed_at":"2025-03-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:05.079637+00:00","generated_at":"2026-05-25T07:14:07.583120+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Foghorn Therapeutics reports 2024 net loss $86.6M; cash runway into 2027; key pipeline milestones","bullets":["Net loss of $86.6M for FY2024 vs $98.4M in 2023; collaboration revenue $22.6M (down from $34.2M).","Cash, equivalents and marketable securities $243.7M as of Dec 31, 2024, providing cash runway into 2027.","FHD-909 Phase 1 trial enrolling for SMARCA4-mutated cancers (NSCLC primary); preclinical combo data at AACR 2025.","Selective degradation of ARID1B achieved; program update expected in 2025. CBP and EP300 degraders progressing towards IND.","Research and development expenses $94.5M (down from $109.7M); G&A $28.4M (down from $32.4M)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-25-010916","json":"https://secwatch.observer/filing/0001628280-25-010916.json","markdown":"https://secwatch.observer/filing/0001628280-25-010916.md","text":"https://secwatch.observer/filing/0001628280-25-010916.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1822462/000162828025010916/0001628280-25-010916-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1822462/000162828025010916/fhtx-20250306.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-25T07:14:07.583120+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}